The rise of pinnacle reefs : a step change in marine evolution triggered by perturbation of the global carbon cycle

The first appearance of pinnacle reef tracts, composed of hundreds to thousands of localized biogenic structures protruding tens to hundreds of meters above the surrounding mid-Silurian seafloor, represents a step change in the evolution of the marine biosphere. This change in seafloor morphology opened a host of new ecological niches that served as "evolutionary cradles" for organism diversification. However, the exact timing and driver's of this event remain poorly understood. These uncertainties remain, in large part, due to a paucity of index fossils in the reef facies, the difficulty of correlating between the offshore pinnacle reefs and more temporally well-constrained shallow marine fades, and cryptic unconformities that separate amalgamated reefs. Here we use delta C-13(carb) stratigraphy within a sequence stratigraphic framework to unravel these complex relationships and constrain the origination of Silurian pinnacle reef tracts in the North American midcontinent to near the Pt. celloni Superzone-Pt. am. amorphognathoides Zonal Group boundary of the mid-Telychian Stage. In addition, we identify a striking relationship between pulses of reef development and changes in global delta C-13(carb) values and sea level. Viewed through this new perspective, we correlate prolific periods of reef development with short-lived carbon isotope (delta C-13(carb)) excursions and eustatic sea level change that, ultimately, reflect perturbations to the global carbon cycle. From changes in the dominance of microbial reefs of the Cambrian to metazoan colonization of reefs in the Middle Ordovician, through the subsequent collapse of metazoan diversity with the Late Ordovician mass extinction, and the first appearance of early Silurian (Llandovery) pinnacle reef tracts and their proliferation during the late Silurian (Wenlock-Pridoli) and Devonian, major reef formation intervals increasingly coincide with delta C-13(carb) excursions. These patterns suggest that Paleozoic reef evolution was the product of environmental forcing by perturbations of the global carbon cycle

New pixelized Micromegas detector for the COMPASS experiment

New Micromegas (Micro-mesh gaseous detectors) are being developed in view of the future physics projects planned by the COMPASS collaboration at CERN. Several major upgrades compared to present detectors are being studied: detectors standing five times higher luminosity with hadron beams, detection of beam particles (flux up to a few hundred of kHz/mm^2, 10 times larger than for the present detectors) with pixelized read-out in the central part, light and integrated electronics, and improved robustness. Studies were done with the present detectors moved in the beam, and two first pixelized prototypes are being tested with muon and hadron beams in real conditions at COMPASS. We present here this new project and report on two series of tests, with old detectors moved into the beam and with pixelized prototypes operated in real data taking condition with both muon and hadron beams.Comment: 11 pages, 5 figures, proceedings to the Micro-Pattern Gaseous Detectors conference (MPGD2009), 12-15 June 2009, Kolympari, Crete, Greece Minor details added and language corrections don

The PANDA GEM-based TPC Prototype

We report on the development of a GEM-based TPC prototype for the PANDA experiment. The design and requirements of this device will be illustrated, with particular emphasis on the properties of the recently tested GEM-detector, the characterization of the read-out electronics and the development of the tracking software that allows to evaluate the GEM-TPC data.Comment: submitted to NIMA 4 pages, 6 picture

Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017.

This is a report on the CNS barrier congress held in London, UK, March 22-23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers

A study of the perceived risks, benefits and barriers to the use of SDD in adult critical care units (the SuDDICU study)

Peer reviewedPublisher PD

Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment

BACKGROUND: Determination of HIV-1 tropism is a pre-requisite to the use of CCR5 antagonists. This study evaluated the potential of population genotypic tropism tests (GTTs) in clinical practice, and the correlation with phenotypic tropism tests (PTTs) in patients accessing routine HIV care. METHODS: Forty-nine consecutive plasma samples for which an original Trofile(TM) assay was performed were obtained from triple-class-experienced patients in need of a therapy change. Viral tropism was defined as the consensus of three or more tropism calls obtained from the combination of two independent population PTT assays (Trofile Biosciences, San Francisco, CA, USA, and Virco, Beerse, Belgium), population GTTs and GTTs based on ultra-deep sequencing. If no consensus was reached, a clonal PTT was performed in order to finalize the tropism call. This two-step approach allowed the definition of a reference tropism call. RESULTS: According to the reference tropism result, 35/49 samples were CCR5 tropic (R5) (patients eligible for maraviroc treatment) and 14/49 were assigned as non-R5 tropic. The non-R5 samples [patients not eligible for maraviroc treatment according to the FDA/European Medicines Agency (EMEA) label] group included both the CXCR4 (X4) samples and the dual and mixed CCR5/CXCR4 (R5/X4) samples. Compared with Trofile(TM) population PTTs, population GTTs showed a higher sensitivity (97%) and a higher negative predictive value (91%), but almost equal specificity and an equal positive predictive value. CONCLUSIONS: In line with recent reports from clinical trial data, our data support the use of population genotypic tropism testing as a tool for tropism determination before the start of maraviroc